Regulation of the adaptive immune response by chemokine scavenging receptors
In plain English
AI plain-English summaryWhen bacteria or viruses invade the body, specialised proteins called chemokines direct immune cells to the right place—and this project studies molecules that can degrade those chemokines, effectively turning off the signal. The problem is that immune responses must be carefully controlled. If cell movement is not properly regulated, the immune system can either fail to fight an infection or, worse, overreact and cause damage. The researchers have identified "scavenger" molecules that remove chemokines from the surroundings, but their precise roles in shaping an immune response remain poorly understood. This project aims to fill that gap by studying how these scavengers work in detail. If successful, the work could lead to new anti-inflammatory treatments for diseases such as arthritis and psoriasis, where chemokines drive harmful inflammation. The team plans to partner with a pharmaceutical company to develop therapeutic agents based on these scavenger molecules. At its core, however, this is fundamental science—understanding a previously overlooked layer of immune regulation. Past discoveries in chemokine biology have already led to drugs that block immune cell migration; this research could open a complementary strategy: not blocking the signal, but clearing it away.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Research GrantPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know